860 related articles for article (PubMed ID: 32711530)
41. Integrated cervical cancer screening in Mayuge District Uganda (ASPIRE Mayuge): a pragmatic sequential cluster randomized trial protocol.
Nakisige C; Trawin J; Mitchell-Foster S; Payne BA; Rawat A; Mithani N; Amuge C; Pedersen H; Orem J; Smith L; Ogilvie G
BMC Public Health; 2020 Jan; 20(1):142. PubMed ID: 32005202
[TBL] [Abstract][Full Text] [Related]
42. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
Devotta K; Vahabi M; Prakash V; Lofters A
BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
[TBL] [Abstract][Full Text] [Related]
43. Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.
Mensah K; Assoumou N; Duchesne V; Pourette D; DeBeaudrap P; Dumont A
BMC Womens Health; 2020 Jul; 20(1):155. PubMed ID: 32723350
[TBL] [Abstract][Full Text] [Related]
44. Knowledge and Attitudes of Bangkok Metropolitan Women towards HPV and Self-Sampled HPV Testing.
Kittisiam T; Tangjitgamol S; Chaowawanit W; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(5):2445-51. PubMed ID: 27268612
[TBL] [Abstract][Full Text] [Related]
45. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
[TBL] [Abstract][Full Text] [Related]
46. Cervical cancer management in Zimbabwe (2019-2020).
Zibako P; Tsikai N; Manyame S; Ginindza TG
PLoS One; 2022; 17(9):e0274884. PubMed ID: 36129898
[TBL] [Abstract][Full Text] [Related]
47. Knowledge, attitudes, and practices among Saudi women regarding cervical cancer, human papillomavirus (HPV) and corresponding vaccine.
Jradi H; Bawazir A
Vaccine; 2019 Jan; 37(3):530-537. PubMed ID: 30503079
[TBL] [Abstract][Full Text] [Related]
48. Healthcare providers' perspectives on the acceptability and uptake of HPV vaccines in Zimbabwe.
Crann SE; Barata PC; Mitchell R; Mawhinney L; Thistle P; Chirenje ZM; Stewart DE
J Psychosom Obstet Gynaecol; 2016 Dec; 37(4):147-155. PubMed ID: 27400371
[TBL] [Abstract][Full Text] [Related]
49. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
[TBL] [Abstract][Full Text] [Related]
50. Knowledge of Thai women in cervical cancer etiology and screening.
Khomphaiboonkij U; Sreamsukcharoenchai N; Pitakkarnkul S; Rittiluechai K; Tangjitgamol S
PLoS One; 2023; 18(5):e0286011. PubMed ID: 37200337
[TBL] [Abstract][Full Text] [Related]
51. Re-valuation of annual cytology using HPV self-sampling to upgrade prevention (REACH UP): A feasibility study in women living with HIV in the UK.
Cicconi P; Wells C; McCarthy B; Wareing S; Andersson MI; Fox J; Lwanga J; Pal N; Burns F; Woodward C; Malek R; Sabin CA; Dorrell L
HIV Med; 2022 Apr; 23(4):390-396. PubMed ID: 35243750
[TBL] [Abstract][Full Text] [Related]
52. Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria.
Akinnibosun O; Abakpa OG; Ujoh AJ; Oche DA; Zakari S; Yandev D; Adikwu P; David OO; Agboola O; Paul S; Audu O; Odu E; Ujah IAO; Anejo-Okopi J
Ethiop J Health Sci; 2024 Jan; 34(1):15-26. PubMed ID: 38370567
[TBL] [Abstract][Full Text] [Related]
53. Awareness and Knowledge of Human Papilloma Virus and Cervical Cancer in Women with High Pap Uptake.
Alafifi R; Kindratt TB; Pagels P; Saleh N; Gimpel NE
J Community Health; 2019 Apr; 44(2):332-338. PubMed ID: 30415376
[TBL] [Abstract][Full Text] [Related]
54. Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: a cross-sectional study.
de Silva AHW; Samarawickrema N; Kasturiratne A; Skinner SR; Wickremasinghe AR; Garland SM
Sex Health; 2019 Jun; 16(3):212-217. PubMed ID: 31088609
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
[TBL] [Abstract][Full Text] [Related]
56. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
57. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia.
Sy AU; Hernandez BY; Tareg A; Reichhardt M; Buenconsejo-Lum L
Cancer Epidemiol; 2017 Oct; 50(Pt B):283-288. PubMed ID: 29120838
[TBL] [Abstract][Full Text] [Related]
58. Self-sampling in Human Papillomavirus screening during and post-COVID-19 pandemic.
Tan CS; Hamzah ND; Ismail ZHF; Jerip AR; Kipli M
Med J Malaysia; 2021 May; 76(3):298-303. PubMed ID: 34031326
[TBL] [Abstract][Full Text] [Related]
59. Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening.
Chatzistamatiou K; Vrekoussis T; Tsertanidou A; Moysiadis T; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moschaki V; Ntoula M; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Daponte A; Vanakara P; Paschopoulos M; Stefos T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Deligeoroglou E; Panoskaltsis T; Adonakis G; Michail G; Stamatopoulos K; Agorastos T
J Womens Health (Larchmt); 2020 Nov; 29(11):1447-1456. PubMed ID: 32757997
[No Abstract] [Full Text] [Related]
60. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
